AU3325493A - Peptide nucleic acids and their effect on genetic material - Google Patents

Peptide nucleic acids and their effect on genetic material

Info

Publication number
AU3325493A
AU3325493A AU33254/93A AU3325493A AU3325493A AU 3325493 A AU3325493 A AU 3325493A AU 33254/93 A AU33254/93 A AU 33254/93A AU 3325493 A AU3325493 A AU 3325493A AU 3325493 A AU3325493 A AU 3325493A
Authority
AU
Australia
Prior art keywords
formula
alkyl
compound
nucleoside base
oligomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU33254/93A
Other languages
English (en)
Inventor
Stewart A Noble
Daniel J. Ricca
Stephen A Thomson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
Glaxo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Inc filed Critical Glaxo Inc
Publication of AU3325493A publication Critical patent/AU3325493A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003Peptide-nucleic acids (PNAs)
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10Alpha-amino-carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU33254/93A 1991-12-18 1992-12-17 Peptide nucleic acids and their effect on genetic material Abandoned AU3325493A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80966191A 1991-12-18 1991-12-18
US809661 1991-12-18

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU70325/96A Division AU7032596A (en) 1991-12-18 1996-10-21 Peptide nucleic acids and their effect on genetic material

Publications (1)

Publication Number Publication Date
AU3325493A true AU3325493A (en) 1993-07-19

Family

ID=25201908

Family Applications (2)

Application Number Title Priority Date Filing Date
AU33254/93A Abandoned AU3325493A (en) 1991-12-18 1992-12-17 Peptide nucleic acids and their effect on genetic material
AU70325/96A Abandoned AU7032596A (en) 1991-12-18 1996-10-21 Peptide nucleic acids and their effect on genetic material

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU70325/96A Abandoned AU7032596A (en) 1991-12-18 1996-10-21 Peptide nucleic acids and their effect on genetic material

Country Status (10)

Country Link
EP (1) EP0618923A4 (no)
JP (1) JPH07502509A (no)
AU (2) AU3325493A (no)
CA (1) CA2125966A1 (no)
FI (1) FI942935A (no)
MX (1) MX9207334A (no)
NO (1) NO942327D0 (no)
NZ (1) NZ246473A (no)
WO (1) WO1993012129A1 (no)
ZA (1) ZA929764B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU676349B2 (en) * 1993-09-13 1997-03-06 Bayer Aktiengesellschaft Nucleic acid-binding oligomers possessing N-branching for therapy and diagnostics

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993013121A1 (en) * 1991-12-24 1993-07-08 Isis Pharmaceuticals, Inc. Gapped 2' modified oligonucleotides
US6713602B1 (en) 1991-05-24 2004-03-30 Ole Buchardt Synthetic procedures for peptide nucleic acids
US6451968B1 (en) 1991-05-24 2002-09-17 Isis Pharmaceuticals, Inc. Peptide nucleic acids
US7223833B1 (en) 1991-05-24 2007-05-29 Isis Pharmaceuticals, Inc. Peptide nucleic acid conjugates
US6441130B1 (en) 1991-05-24 2002-08-27 Isis Pharmaceuticals, Inc. Linked peptide nucleic acids
US6228982B1 (en) * 1992-05-22 2001-05-08 Benget Norden Double-stranded peptide nucleic acids
US5539082A (en) * 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
DK51092D0 (da) 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
US5700922A (en) * 1991-12-24 1997-12-23 Isis Pharmaceuticals, Inc. PNA-DNA-PNA chimeric macromolecules
US6277603B1 (en) 1991-12-24 2001-08-21 Isis Pharmaceuticals, Inc. PNA-DNA-PNA chimeric macromolecules
US6350853B1 (en) 1993-04-26 2002-02-26 Peter E. Nielsen Conjugated peptide nucleic acids having enhanced cellular uptake
US5527675A (en) * 1993-08-20 1996-06-18 Millipore Corporation Method for degradation and sequencing of polymers which sequentially eliminate terminal residues
WO1995017403A1 (en) * 1993-12-22 1995-06-29 Perseptive Biosystems, Inc. Guanine synthons for peptide nucleic acid synthesis and method for production
US6133444A (en) * 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
DK145493D0 (da) * 1993-12-23 1993-12-23 Dako As Antistof
US5539083A (en) * 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
DE4408533A1 (de) * 1994-03-14 1995-09-28 Hoechst Ag PNA-Synthese unter Verwendung einer basenlabilen Amino-Schutzgruppe
DE4408531A1 (de) * 1994-03-14 1995-09-28 Hoechst Ag PNA-Synthese unter Verwendung einer gegen schwache Säuren labilen Amino-Schutzgruppe
DE4408534A1 (de) * 1994-03-14 1995-09-28 Hoechst Ag Substituierte N-Ethyl-Glycinderivate zur Herstellung von PNA und PNA-/DNA-Hybriden
DE4427980A1 (de) * 1994-08-08 1996-02-15 Bayer Ag Nukleinsäuren-bindende Oligomere für Therapie und Diagnostik
ATE222589T1 (de) * 1994-10-06 2002-09-15 Isis Pharmaceuticals Inc Peptid-nukleinsäure-konjugate
AU4729796A (en) * 1994-12-28 1996-07-19 Peter E. Nielsen Peptide nucleic acid incorporating a chiral backbone
US6465650B1 (en) 1995-03-13 2002-10-15 Aventis Pharma Deutschland Gmbh Substituted N-ethylglycine derivatives for preparing PNA and PNA/DNA hybrids
EP0840741B1 (en) * 1995-06-07 2004-04-28 Perseptive Biosystems, Inc. Pna-dna chimeras and pna synthons for their preparation
WO1997014793A1 (en) * 1995-10-20 1997-04-24 Trustees Of Boston University Nucleic acid clamps
DE19653646A1 (de) * 1996-12-20 1998-06-25 Hoechst Ag Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung
US6617422B1 (en) 1997-05-23 2003-09-09 Peter Nielsen Peptide nucleic acid monomers and oligomers
WO1998058256A1 (en) * 1997-06-16 1998-12-23 The University Of North Carolina At Chapel Hill PEPTIDO OLIGONUCLEOTIDES (PONs) AND THEIR COMBINATORIAL LIBRARIES
AU9064598A (en) * 1998-07-10 2000-02-01 Harald Groger Precusors for pna-monomers
US6921812B1 (en) 2001-07-03 2005-07-26 Isis Pharmaceuticals, Inc. Methods of modulating pharmacokinetics of oligonucleotides
HUE033832T2 (en) 2002-11-15 2018-01-29 Idenix Pharmaceuticals Llc 2'-methyl nucleosides in combination with interferon and Flaviviridae mutation
WO2007073149A1 (en) 2005-12-22 2007-06-28 Keygene N.V. Alternative nucleotides for improved targeted nucleotide exchange
WO2012113775A1 (en) 2011-02-21 2012-08-30 University Of Zurich Ankyrin g and modulators thereof for the treatment of neurodegenerative disorders
WO2014152054A1 (en) 2013-03-15 2014-09-25 Bio-Rad Laboratories, Inc. Digital assays for mutation detection
AU2018240467B2 (en) * 2017-03-23 2022-09-15 Neubase Therapeutics, Inc. Peptide nucleic acid (PNA) monomers with an orthogonally protected ester moiety

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0639582B1 (en) * 1985-03-15 1998-09-16 Antivirals Inc. Polynucleotide assay reagent and method
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU676349B2 (en) * 1993-09-13 1997-03-06 Bayer Aktiengesellschaft Nucleic acid-binding oligomers possessing N-branching for therapy and diagnostics

Also Published As

Publication number Publication date
MX9207334A (es) 1993-08-01
NO942327L (no) 1994-08-17
NZ246473A (en) 1996-05-28
CA2125966A1 (en) 1993-06-24
ZA929764B (en) 1993-10-13
WO1993012129A1 (en) 1993-06-24
FI942935A0 (fi) 1994-06-17
EP0618923A4 (en) 1998-05-20
JPH07502509A (ja) 1995-03-16
FI942935A (fi) 1994-07-27
NO942327D0 (no) 1994-06-17
EP0618923A1 (en) 1994-10-12
AU7032596A (en) 1997-01-16

Similar Documents

Publication Publication Date Title
AU3325493A (en) Peptide nucleic acids and their effect on genetic material
US5623049A (en) Nucleic acid-binding oligomers possessing N-branching for therapy and diagnostics
JP3326181B2 (ja) 連結ペプチド核酸
US20210189392A1 (en) S-antigen transport inhibiting oligonucleotide polymers and methods
CN105669751B (zh) 非环核苷酸磷酰胺类化合物及其盐的制备以及在抗病毒方面的应用
KR20220163960A (ko) 변경된 짧은 개재성 핵산(siNA) 분자 및 이의 용도
CN111032672A (zh) 作为抗癌剂的环二核苷酸
CA2498772A1 (en) Modified pna molecules
MX2010009687A (es) Derivados de acido nucleico peptidico con buena penetracion celular y fuerte afinidad por acido nucleico.
KR19980703203A (ko) 신규 펩티드 유도체
US5849893A (en) Nucleic acid-binding oligomers possessing C-branching for therapy and diagnostics
JP6546272B2 (ja) ペプチド核酸モノマー及びオリゴマー
KR20230119637A (ko) 폴리-모르폴리노 올리고뉴클레오티드 갭머
WO2020146521A2 (en) Rnai agents for inhibiting expression of hif-2 alpha (epas1), compositions thereof, and methods of use
US6670468B1 (en) 2′-substituted nucleosides and oligonucleotide derivatives
US20220195437A1 (en) Tau-targeting oligonucleotide gapmers
WO2000002864A1 (en) Precusors for pna-monomers
TW200813066A (en) Novel compounds
JP2004514427A (ja) Pna類似物
CN108201539B (zh) 联苯核苷氨基磷酸酯化合物的应用
KR20220119052A (ko) 합성 공정 및 중간체
JP2021506313A (ja) 二価核酸リガンドおよびその使用
US8350042B2 (en) Antiviral compounds for the treatment of HCV infection
EP0558749A1 (en) Antisense nucleic acid derivative
KR100255526B1 (ko) C-반응성 단백질 단편의 부분적으로 변형되고 역-전화된 테트라펩티드 유사체